Mary Ann Liebert, Inc., publishers

Even after being frozen for 18 years, human embryos can be thawed, grown in the laboratory, and successfully induced to produce human embryonic stem (ES) cells, which represent a valuable resource for drug screening and medical research.

Despite criticism from Congressional Republicans and other groups, the U.S. Navy recently completed its Rim of the Pacific (RIMPAC) 2012 international maritime exercises, featuring the “Great Green Fleet” powered by a 50% biofuels blend.

The body’s natural reaction to reject replacement proteins represents a major obstacle to the successful use of gene therapy to cure a range of life-threatening diseases.

The global market value of Alzheimer's disease therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease, reports Genetic Engineering & Biotechnology News (GEN).

Genetic Engineering & Biotechnology News (GEN) has launched a unique microsite called Biotech Boulevard.

Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma.

A novel approach to gene therapy that instructs a person’s own cells to produce more of a natural disease-fighting protein could offer a solution to treating many genetic disorders.

A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies.

To enable greater reliance on renewable biomass resources for power generation, combination approaches such as co-firing of high percentages of biomass with coal offer unique advantages, but also significant challenges.

A small, naturally occurring nucleic acid sequence, called a microRNA, known to regulate a number of different cancers, appears to alter the activity of the androgen receptor, which plays a critical role in prostate cancer.